Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Clinical trial NCT02134366 · TERMINATED

Trial details

NCT number: NCT02134366
Sponsor: The Cooper Health System
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Epilepsia Partialis Continua Kojewnikov's Epilepsy Epilepsy

Start date: 2014-07-01
Primary completion: 2017-07-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.